a16z Capital Management, L.L.C.
Q3 2026 13F-HR Holdings
Net value change ($000)
+5,678,165
(39.9%)
New positions
6
Sold out positions
1
Turnover %
2.5%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2026
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| SPACE EXPLORATION TECHN CORP | 5,581,671 | 43.6% |
| BRAVEHEART BIO INC | 206,695 | NEW |
| FREENOME INC | 87,753 | NEW |
| NEUTRON HOLDINGS INC | 80,259 | NEW |
| SCRIBE THERAPEUTICS INC | 56,738 | NEW |
| STANDARD NUCLEAR INC | 34,543 | NEW |
| BLOSSOMHILL THERAPEUTICS INC | 2,330 | NEW |
| BTGO | 1,479 | 42.8% |
| DNA | 317 | 29.5% |
| IP STRATEGY HOLDINGS INC | 3 | 30.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|